Business Segments ICON Public Limited Company
Equities
ICLR
IE0005711209
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 186.58 USD | -1.76% |
|
+0.38% | -11.03% |
| Dec. 09 | ICON plc Releases Findings from Two Biotech Sector Survey | CI |
| Dec. 02 | Icon survey reveals increasing clinical trial startup delays | RE |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Life Sciences Tools and Services | ||||||||||
Medical Labs & Research | 2.8B | 5.48B | 7.74B | 8.12B | 8.28B | |||||
Total Assets | 3.44B | 17.39B | 17.19B | 16.99B | 16.88B | |||||
Interest Expense | -13.02M | -182M | -230M | -337M | -237M | |||||
Income Tax Expense | 47.88M | 41.33M | 59.41M | 11.75M | 77.71M | |||||
CAPEX | -51.06M | -93.75M | -142M | -141M | -168M | |||||
EBT | 381M | 197M | 568M | 624M | 869M | |||||
D&A | 94.61M | 315M | 570M | 586M | 488M | |||||
Operating Income | 392M | 379M | 795M | 956M | 1.1B | |||||
Net Income | 332M | 153M | 505M | 612M | 791M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States (U.S.) | 926M | 2.58B | 3.57B | 3.28B | 2.99B | |||||
Total Assets | 909M | 240M | 213M | 159M | 145M | |||||
Income Tax Expense | 7.6M | - | - | - | - | |||||
D&A | 36.06M | - | - | - | - | |||||
CAPEX | -14.35M | - | - | - | - | |||||
Operating Income | 57.68M | 232M | 255M | 310M | 242M | |||||
Ireland | 1.18B | 1.37B | 1.98B | 2.38B | 2.79B | |||||
Total Assets | 1.68B | 118M | 143M | 199M | 234M | |||||
Income Tax Expense | 30.62M | - | - | - | - | |||||
D&A | 33.52M | - | - | - | - | |||||
CAPEX | -29.31M | - | - | - | - | |||||
Operating Income | 295M | 162M | 218M | 432M | 919M | |||||
Rest of Europe | 417M | 1.18B | 1.62B | 1.57B | 1.56B | |||||
Total Assets | 671M | 121M | 99.72M | 94.05M | 88.56M | |||||
Income Tax Expense | 4.61M | - | - | - | - | |||||
D&A | 18.57M | - | - | - | - | |||||
CAPEX | -9.3M | - | - | - | - | |||||
Operating Income | 35.4M | 183M | 254M | 153M | 217M | |||||
Rest of world | 274M | 358M | 564M | 884M | 943M | |||||
Total Assets | 179M | 55.31M | 48.1M | 49.18M | 62.36M | |||||
Income Tax Expense | 5.05M | - | - | - | - | |||||
D&A | 11.87M | - | - | - | - | |||||
CAPEX | -10.2M | - | - | - | - | |||||
Operating Income | 21.15M | 30.63M | 68.5M | 60.33M | 70.66M |
- Stock Market
- Equities
- ICLR Stock
- Financials ICON Public Limited Company
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
